Seagate Technology PLC (commonly referred to as Seagate) is an American data storage company. It was incorporated in 1978, as Shugart Technology. Since 2010, the company is incorporated in Dublin, Ireland, with operational headquarters in Cupertino, California, United States. David Mosley is the current CEO with Stephen J. Luczo as chairman of the board of directors. In January 2009, Luczo, Seagate's chairman, was appointed president and chief executive officer, returning him to the role he held at Seagate from 1998 to 2004. On October 2, 2017 COO David Mosley was appointed CEO and Luczo stepped down from that role.

CEA is a French government-funded technological research organisation. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world. The CEA is the French Alternative Energies and Atomic Energy Commission (Commissariat à l'énergie atomique et aux énergies alternatives). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and researchers, building on the synergies between fundamental and technological research. The total CEA workforce consisted of 15 838 employees. Across the whole of the CEA (including both civilian and military research), there were 1556 PhD students and 293 post-docs. The CEA is based in ten research centers in France, each specializing in specific fields. The laboratories are located in the Paris region, the Rhône-Alpes, the Rhône valley, the Provence-Alpes-Côte d'Azur region, Aquitaine, Central France and Burgundy. The CEA benefits from the strong regional identities of these laboratories and the partnerships forged with other research centers, local authorities and universities.

FEI EFA, Inc. designs and manufactures electronic semiconductors. The firm develops and sells circuit analysis and edit tool for wafer and package semiconductor products. It provides Meridian WaferScan for backside wafer-level analysis. The company was founded by Israel Niv in 2008 and is headquartered in Fremont, CA.

Quantum-Si is focused on revolutionizing the growing field of proteomics. The company’s suite of technologies are powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

Part of Bright Bidco BV, Lumileds Holding BV is a company headquartered in Schiphol, the Netherlands. The firm manufactures and markets light-emitting diodes and automotive lighting products. Steve Barlow is the current CEO, occupying that position since 2003.\nThe company says this about itself: Lumileds is a global leader in OEM and aftermarket automotive lighting and accessories, camera flash for mobile devices, MicroLED, and light sources for general illumination, horticulture, and human-centric lighting. Our approximately 7,000 employees operate in over 30 countries and partner with our customers to deliver never before possible solutions for lighting, safety, and well-being.

Siemens Medical Solutions USA, Inc. provides medical products and solutions. It offers imaging systems, therapy equipment, and hearing instruments for diagnosis, treatments, and patient monitoring. The firm services include imaging and therapy, customer resources and logins, healthcare financing solutions and laboratory diagnostics services. The company was founded in 1896 and is headquartered in Malvern, PA.

ASML Netherlands BV, a subsidiary of ASML Holding NV, is a company headquartered in Veldhoven, the Netherlands. The firm manufactures and supplies chip-making equipment.\nThe company says this about itself: ASML is one of the world's leading manufacturers of chip-making equipment. Our vision is to enable affordable microelectronics that improve the quality of life. To achieve this, our mission is to invent, develop, manufacture and service advanced technology for high-tech lithography, metrology and software solutions for the semiconductor industry. ASML's guiding principle is continuing Moore's Law towards ever smaller, cheaper, more powerful and energy-efficient semiconductors. This results in increasingly powerful and capable electronics that enable the world to progress within a multitude of fields, including healthcare, technology, communications, energy, mobility, and entertainment. ASML is a multinational company with offices in 60 cities in 16 countries, headquartered in Veldhoven, the Netherlands. We employ more than 19,000 people on payroll and flexible contracts (expressed in full time equivalents). ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML.

Guangdong Aglaia Optoelectronic Materials Co., Ltd., established on 2010-11-05, The scope of business includes the development of optoelectronic molecular functional materials and their application technologies,Production,processing,transfer,to promote,consult,Serve,Sales:computer,Software and Auxiliary Equipment,electronic product,Equipment,communication equipment,hardware,AC,Chemical Products,Operating and acting as an agent for the import and export of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Orange S.A., formerly France Télécom S.A., is a French multinational telecommunications corporation. It has 256 million customers worldwide and employs 95,000 people in France, and 59,000 elsewhere. It is the tenth largest mobile network operator in the world and the fourth largest in Europe after Vodafone, Telefónica and VEON. In 2015, the group had revenue of €40 billion. The company's head office is located in the 15th arrondissement of Paris. The current CEO is Stéphane Richard. The company is a component of the Euro Stoxx 50 stock market index.

NeuroLogica Corp. develops, manufactures and markets medical imaging equipment. Its products include ceretom portable CT scanner and digital radiography. The firm offers customer service, technical support and sales services. The company was founded by Eric M. Bailey, Bernard M. Gordon and Andrew P. Tybinkowski in 2004 and is headquartered in Danvers, MA.

Devicor Medical Products, Inc. engages in acquiring medical device companies and products. Its products include mommotome revolve, elite, tissue markers, neoprene, specimen radiograph, mammo test and stereo solutions. The company was founded in 2008 and is headquartered in Cincinnati, OH.

Valco Instruments Co. LP is an American private company located in Houston, TX, with a presence in Switzerland, that manufactures fluid power pumps & motors and automation equipment.

Johnson & Johnson Vision Care is committed to creating life-long solutions to vision care needs. Since the ACUVUE Brand made its debut in 1987 as the world’s first disposable soft contact lens, the company has repeatedly brought quality, scientific and innovative advancements to the industry. Headquartered in Jacksonville, Florida, the company has some 3,000 employees worldwide.

The French Institut de radioprotection et de sûreté nucléaire (IRSN) ("Radioprotection and Nuclear Safety Institute") located in Fontenay-aux-Roses is a public official establishment with an industrial and commercial aspect (EPIC) created by the AFSSE Act (Agence française de sécurité sanitaire de l'environnement et du travail (fr) - French Agency of Sanitary Environmental Security) and by February 22, 2002 decreed n°2002-254. The IRSN is placed under the conjoint authority of the Defence minister, the Environmental minister, the Industry minister and the Health and Research minister.

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. David R. Walt, Satnam Alag, Larry Bock, and John Stuelpnagel co-founded Illumina in San Diego, California in 1998.

Part of Thermo Fisher Scientific, Inc., Thermo Gamma-Metrics LLC is an American company located in San Diego, CA, that manufactures and sells processing equipment. The firm was founded by James F. Miller and Clinton L. Lingren.

Toshiba Research Europe Ltd., a subsidiary of TOSHIBA Corp., is a British company located in Cambridge. The firm operates Toshiba's Cambridge research laboratory and telecommunication research. It was founded in 1990. Hitoshi Otsuka is the current CEO of the firm.\nThe company says this about itself: The Cambridge Research Laboratory of Toshiba Research Europe Ltd conduct research on Computer Vision, Speech and Quantum Technologies. The Quantum Information Group is exploring the ultimate limit of Information Technology in which each bit is encoded on a single electron or photon. Notable past achievements include the first Quantum Cryptography system to operate over 100 km of fibre, the first to operate with a secure key rate of 10 Mbit/sec and the first semiconductor light emitting diodes for single photons and entangled pairs.

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) focuses on the development of innovative immunodiagnostic agents and immunotherapeutics to enhance patient care by identifying the sites and pathways of disease and enable better diagnostic accuracy, clinical decision-making, and targeted treatment. Patients and physicians, aspire to provide innovative immunodiagnostic agents and therapies to improve patient care for serious diseases. For investors, they aim to deliver superior growth through their focus on developing their innovative Manocept™ platform and driving efficient business processes. For their employees, they provide a culture that focuses on the direct contributions their efforts make for the patients they serve and an innovative development environment for new breakthrough products.